FUSIONED IMIDAZO-PIPERIDINE COMPOUNDS AS JAK INHIBITORS
Номер патента: AR111495A1
Опубликовано: 17-07-2019
Автор(ы): Glenn D Crater, HAO Zhang, Jerry Nzerem, Lan Jiang, Marta Dabros, Melanie A Kleinschek, NOAH Benjamin, Paul R Fatheree, Robert Murray Mkinnell, Venkat R Thalladi
Принадлежит: Theravance Biopharma R&D Ip Llc
Опубликовано: 17-07-2019
Автор(ы): Glenn D Crater, HAO Zhang, Jerry Nzerem, Lan Jiang, Marta Dabros, Melanie A Kleinschek, NOAH Benjamin, Paul R Fatheree, Robert Murray Mkinnell, Venkat R Thalladi
Принадлежит: Theravance Biopharma R&D Ip Llc
Реферат: Un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, útil como inhibidor de JAK. Formas cristalinas del compuesto, composiciones farmacéuticas que comprenden tal compuesto, métodos para usar el compuesto para tratar enfermedades susceptibles a un inhibidor de JAK, y procesos e intermediarios útiles para preparar el compuesto. A compound of formula (1), or a pharmaceutically acceptable salt thereof, useful as a JAK inhibitor. Crystal forms of the compound, pharmaceutical compositions comprising such a compound, methods for using the compound to treat diseases susceptible to a JAK inhibitor, and processes and intermediates useful for preparing the compound.
Fused imidazo-piperidine jak inhibitor compound
Номер патента: US20220008428A1. Автор: Lan Jiang,Paul R. Fatheree. Владелец: Theravance Biopharma R&D Ip Llc. Дата публикации: 2022-01-13.